IPO
Hong Kong biotech Prenetics tumbles after Nasdaq debut
CEO warns key COVID-19 testing business to drop as pandemic recedes
Virus test provider helped soccer's Premier League resume play
Global supplies shortage and dependence on West spell urgency, opportunity
Big names, startups race for ways to offer comfort, data and right mindset
Smartphone app guides users through stroke recovery with help from AI
Japanese drugmaker also says vaccine proven effective in trials
Would mark country's biggest deal so far this year
Jab, different from Pfizer and Moderna's mRNA vaccines, provides 'diversity'
Aging population sparks need for services but cost pressures limit profitability
Failure to strike gold with Aduhelm prompts renewed focus on successor
Mixed variant has traits of delta and omicron, but details still scarce
2Q profit plunges 97% as selling prices decline for medical-grade products
Mobility startup LifeHub raises more than $800,000 in seed funding
Majority of growth investment set aside for these segments for 1st time
Underserved by mainstream health care, women from India to Japan turn to technology
Research group urges tighter rein on hospitals and speedier drug authorization
Overseas sales boom as omicron rages, but pandemic's end will clip windfall
Chinese leader calls for 'all necessary measures' to stop city's worst outbreak
Concerns over supply emerge as nations race to secure drugs for their people
People in risk areas shall not leave the capital, city spokesperson says
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.